These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 19227008)
1. Anti-thrombin as a prognostic biomarker candidate for patients with recurrent glioblastoma multiform under treatment with perillyl alcohol. Fischer Jde S; Carvalho PC; Neves-Ferreira AG; da Fonseca CO; Perales J; Carvalho Mda G; Domont GB J Exp Ther Oncol; 2008; 7(4):285-90. PubMed ID: 19227008 [TBL] [Abstract][Full Text] [Related]
2. Chemo-resistant protein expression pattern of glioblastoma cells (A172) to perillyl alcohol. de Saldanha da Gama Fischer J; Costa Carvalho P; da Fonseca CO; Liao L; Degrave WM; da Gloria da Costa Carvalho M; Yates JR; Domont GB J Proteome Res; 2011 Jan; 10(1):153-60. PubMed ID: 20806975 [TBL] [Abstract][Full Text] [Related]
4. Dynamic proteomic overview of glioblastoma cells (A172) exposed to perillyl alcohol. Fischer Jde S; Liao L; Carvalho PC; Barbosa VC; Domont GB; Carvalho Mda G; Yates JR J Proteomics; 2010 Mar; 73(5):1018-27. PubMed ID: 20083244 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation. DA Fonseca CO; Teixeira RM; Silva JC; DE Saldanha DA Gama Fischer J; Meirelles OC; Landeiro JA; Quirico-Santos T Anticancer Res; 2013 Dec; 33(12):5625-31. PubMed ID: 24324108 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide. Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172 [TBL] [Abstract][Full Text] [Related]
7. Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects. Xu M; Floyd HS; Greth SM; Chang WC; Lohman K; Stoyanova R; Kucera GL; Kute TE; Willingham MC; Miller MS Toxicol Appl Pharmacol; 2004 Mar; 195(2):232-46. PubMed ID: 14998688 [TBL] [Abstract][Full Text] [Related]
8. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas. da Fonseca CO; Schwartsmann G; Fischer J; Nagel J; Futuro D; Quirico-Santos T; Gattass CR Surg Neurol; 2008 Sep; 70(3):259-66; discussion 266-7. PubMed ID: 18295834 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol. da Fonseca CO; Landeiro JA; Clark SS; Quirico-Santos T; da Costa Carvalho Mda G; Gattass CR Surg Neurol; 2006; 65 Suppl 1():S1:2-1:8; discussion S1:8-1:9. PubMed ID: 16427438 [TBL] [Abstract][Full Text] [Related]
10. Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial. Oehler C; Frei K; Rushing EJ; McSheehy PM; Weber D; Allegrini PR; Weniger D; Lütolf UM; Knuth A; Yonekawa Y; Barath K; Broggini-Tenzer A; Pruschy M; Hofer S Oncology; 2012; 83(1):1-9. PubMed ID: 22688083 [TBL] [Abstract][Full Text] [Related]
11. Effects of perillyl alcohol in glial C6 cell line in vitro and anti-metastatic activity in chorioallantoic membrane model. Teruszkin Balassiano I; Alves de Paulo S; Henriques Silva N; Curié Cabral M; Gibaldi D; Bozza M; Orlando da Fonseca C; Da Glória da Costa Carvalho M Int J Mol Med; 2002 Dec; 10(6):785-8. PubMed ID: 12430008 [TBL] [Abstract][Full Text] [Related]
12. Circulating Cell-Free DNA as a Prognostic and Molecular Marker for Patients with Brain Tumors under Perillyl Alcohol-Based Therapy. Faria G; Silva E; Da Fonseca C; Quirico-Santos T Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29848970 [TBL] [Abstract][Full Text] [Related]
13. Perillyl alcohol induces c-Myc-dependent apoptosis in Bcr/Abl-transformed leukemia cells. Clark SS Oncology; 2006; 70(1):13-8. PubMed ID: 16439861 [TBL] [Abstract][Full Text] [Related]
15. Effects of perillyl alcohol and heat shock treatment in gene expression of human lung adenocarcinoma cell line A549. Fischer Jde S; Carvalho PC; Gattass CR; Paschoal EM; da Mota e Silva MS; Carvalho Mda G J Exp Ther Oncol; 2006; 5(4):301-7. PubMed ID: 17024970 [TBL] [Abstract][Full Text] [Related]
16. Perillyl alcohol as a chemopreventive agent in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Liston BW; Nines R; Carlton PS; Gupta A; Aziz R; Frankel W; Stoner GD Cancer Res; 2003 May; 63(10):2399-403. PubMed ID: 12750258 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. Bailey HH; Attia S; Love RR; Fass T; Chappell R; Tutsch K; Harris L; Jumonville A; Hansen R; Shapiro GR; Stewart JA Cancer Chemother Pharmacol; 2008 Jun; 62(1):149-57. PubMed ID: 17885756 [TBL] [Abstract][Full Text] [Related]
18. Polycyclic aromatic hydrocarbon-induced CYP1B1 activity is suppressed by perillyl alcohol in MCF-7 cells. Chan NL; Wang H; Wang Y; Leung HY; Leung LK Toxicol Appl Pharmacol; 2006 Jun; 213(2):98-104. PubMed ID: 16307765 [TBL] [Abstract][Full Text] [Related]
19. Perillyl alcohol is an angiogenesis inhibitor. Loutrari H; Hatziapostolou M; Skouridou V; Papadimitriou E; Roussos C; Kolisis FN; Papapetropoulos A J Pharmacol Exp Ther; 2004 Nov; 311(2):568-75. PubMed ID: 15210838 [TBL] [Abstract][Full Text] [Related]
20. Perillyl alcohol mediated radiosensitization via augmentation of the Fas pathway in prostate cancer cells. Rajesh D; Howard SP Prostate; 2003 Sep; 57(1):14-23. PubMed ID: 12886519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]